Clinical trial
Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)
NCT00233740 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00233740 |
|---|---|
| Title | Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF) |
| Official title | The Cordis Protection From Pulmonary Embolism With the Permanent OptEase™ Filter - A Post Marketing Surveillance Study (PROOF Study) |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Embolism |
| Intervention type | Device |
| Interventions | OPTEASE Vena Cava Filter |
| Enrollment | 150 |
| Start date | Sep 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Oct 6, 2005 |
| Last update posted | Aug 5, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: